Article
[Comprehensive genomic profiling in large cell neuroendocrine lung cancer: the times they are a-changin'.]
Recenti progressi in medicina - 1 Jan 2021
Filetti Marco, Piras Marta, Giusti Raffaele
Abstract excerpt
The discovery of gene driver mutations and the increase of next-generation sequencing techniques have radically changed the natural history of NSCLCs. Neuroendocrine lung cancers are a heterogeneous entity whose biology is little known. Sporadic actionable mutations are also reported in this subtype of neoplasms, especially in tumors derived from a transformation of adenocarcinomas. ROS-1 gene rearrangements are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
